Mirtazapine Tablet, Film Coated
Product Images NDC 55154-7297

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-7297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dd924fb7 0484 4b62 8522 9f67d1416919 00

Dd924fb7 0484 4b62 8522 9f67d1416919 00
Mirtazapine Tablets, USP 15 mg film-coated tablet label for a 10-tablet unit dose package. The label includes directions to see the product insert for prescribing information, storage instructions, and warnings. It notes the labeler as Cardinal Health 107, LLC, with manufacturing and distribution details for Apotex Inc and Major Pharmaceuticals.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of mirtazapine, showing its fused ring system and nitrogen-containing functional groups consistent with the active ingredient mirtazapine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.